You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PSMA-PET/CT

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TNBC - Triple-Negative Breast Cancer Trial in Brussels (Ga-PSMA PET/CT)

Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Ga-PSMA PET/CT
  • Brussels, Belgium
    Institut Jules Bordet
Sep 26, 2023

Prostate Cancer Trial ([18F]-PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • [18F]-PSMA-1007
  • (no location specified)
Jan 30, 2023

Cancer Trial in Meldola, Cesena ([177Lu]Lu-PSMA I&T)

Not yet recruiting
  • Cancer
  • [177Lu]Lu-PSMA I&T
  • Meldola, Forlì, Italy
  • +1 more
May 10, 2023

Prostate Cancer Trial in Montreal (68Ga-HBED-CC-PSMA PET/CT)

Enrolling by invitation
  • Prostate Cancer
  • 68Ga-HBED-CC-PSMA PET/CT
  • Montreal, Quebec, Canada
    Jewish General Hospital
Oct 24, 2022

Bladder Cancer Trial in New York ([68Ga]PSMA, PET/CT imaging)

Recruiting
  • Bladder Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 28, 2022

Prostate Cancer Trial in Utrecht (PSMA-PET/CT response evaluation)

Not yet recruiting
  • Prostate Cancer
  • PSMA-PET/CT response evaluation
  • Utrecht, Netherlands
    Roderick van den Bergh
Sep 10, 2022

Hepatocellular Carcinoma Trial in Rochester (Ga-68 labeled PSMA-11, Possible liver biopsy for locoregional therapy group)

Recruiting
  • Hepatocellular Carcinoma
  • Ga-68 labeled PSMA-11
  • Possible liver biopsy for locoregional therapy group
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jul 18, 2022

Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients

Not yet recruiting
  • Prostatic Neoplasms
  • +2 more
    • (no location specified)
    Jan 9, 2023

    Prostate Cancer Trial (Pylarify Piflufolastat Flourine-18 (18F-DCFPyL))

    Not yet recruiting
    • Prostate Cancer
    • Pylarify Piflufolastat Flourine-18 (18F-DCFPyL)
    • (no location specified)
    Jan 26, 2023

    Prostate Cancer Trial in Hefei (18F-PSMA-1007 PET/CT based on diagnostic model)

    Not yet recruiting
    • Prostate Cancer
    • 18F-PSMA-1007 PET/CT based on diagnostic model
    • Hefei, Anhui, China
      The First Affiliated Hospital of USTC
    Dec 6, 2022

    Salivary Gland Cancer, Salivary Duct Carcinoma Trial in Nijmegen (68Ga-PSMA-PET/CT, 18FDG-PET/CT)

    Recruiting
    • Salivary Gland Cancer
    • Salivary Duct Carcinoma
    • 68Ga-PSMA-PET/CT
    • 18FDG-PET/CT
    • Nijmegen, Gelderland, Netherlands
      Radboudumc
    Aug 15, 2022

    Cancer Trial in Montreal (PSMA PET/CT)

    Enrolling by invitation
    • Cancer
    • PSMA PET/CT
    • Montreal, Quebec, Canada
      Jewish General Hospital
    Dec 9, 2021

    Neuroendocrine Tumors, Prostate Cancer Trial in Salt Lake City (Single-Tracer FDG PET/CT Exam, Single-Tracer Cu64-DOTATATE

    Recruiting
    • Neuroendocrine Tumors
    • Prostate Cancer
    • Single-Tracer FDG PET/CT Exam
    • +3 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Dec 27, 2022

    Prostate Cancer Trial in Laval, Montréal, Québec (PSMA -PET/CT simulation, Standard-care simulation)

    Active, not recruiting
    • Prostate Cancer
    • PSMA -PET/CT simulation
    • Standard-care simulation
    • Laval, Quebec, Canada
    • +2 more
    Aug 5, 2022

    Hepatocellular Carcinoma Trial in Rochester (Gallium Ga 68 Gozetotide, Hepatic Artery Embolization, Positron Emission Tomography

    Recruiting
    • Hepatocellular Carcinoma
    • Gallium Ga 68 Gozetotide
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 11, 2023

    Hepatocellular Carcinoma Trial in Fitzroy, Heidelberg, Melbourne (18F-DCFPyL)

    Recruiting
    • Hepatocellular Carcinoma
    • Fitzroy, Victoria, Australia
    • +3 more
    May 17, 2022

    F-18 PSMA for Localization of Parathyroid Adenoma

    Recruiting
    • Hyperparathyroidism
    • 99mTc-MIBI planar imaging and SPECT/CT.
    • F- 18PSMA PET/CT imaging study
    • Atlanta, Georgia
    • +2 more
    Mar 31, 2022

    Clinical Relevance of PSMA Expression in Malignant Gastrointestinal Tumors Trial in Wuerzburg (18F-PSMA PET/CT)

    Recruiting
    • Clinical Relevance of PSMA Expression in Malignant Gastrointestinal Neoplasms
    • 18F-PSMA PET/CT
    • Wuerzburg, Bavaria, Germany
      University Hospital Wuerzburg
    Sep 15, 2022

    Prostate Cancer Trial in Nanjing (68Ga-PSMA-33)

    Recruiting
    • Prostate Cancer
    • Nanjing, Jiangsu, China
      68Ga-PSMA-33 PET/CT imaging
    Sep 19, 2023

    Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)

    Not yet recruiting
    • Medullary Thyroid Cancer
    • +3 more
    • Groningen, Netherlands
      University Medical Centre Groningen
    Sep 8, 2022

    Prostate Cancer Trial in Beijing (Al18F-PSMA-617, 68Ga-PSMA-617)

    Recruiting
    • Prostate Cancer
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 2, 2023

    Prostate Cancer Trial in Canada (PSMA PET/CT guided intensification of therapy, Control Arm)

    Recruiting
    • Prostate Cancer
    • PSMA PET/CT guided intensification of therapy
    • Control Arm
    • Kelowna, British Columbia, Canada
    • +13 more
    Dec 14, 2022

    Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)

    Recruiting
    • Malignancy
    • Al18F-PSMA-BCH PET/CT
    • Beijing, Chaoyang, China
      National Cancer Center/Cancer Hospital,Chinese Academy of Medica
    Mar 7, 2023

    Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston

    Not yet recruiting
    • Advanced Prostate Cancer
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Sep 25, 2023

    Prostate Cancer Trial in Rozzano (PSMA PET/TRUS (trans-rectal or trans-perineal) fusion biopsy)

    Recruiting
    • Prostate Cancer
    • PSMA PET/TRUS (trans-rectal or trans-perineal) fusion biopsy
    • Rozzano, Italy
      IRCCS Humanitas Research Hospital
    Apr 27, 2022